carbon monoxide has been researched along with Chronic Illness in 114 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the pattern of immunoglobulins and cellular constituents in bronchoalveolar lavage fluid obtained from patients with sulfur mustard gas-induced asthma or chronic bronchitis as compared with healthy control subjects." | 7.70 | Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis. ( Emad, A; Rezaian, GR, 1999) |
| "The effects of carbon monoxide on exercise tolerance as assessed by the distance walked in 12 minutes were studied in 15 patients with severe chronic bronchitis and emphysema (mean forced expiratory volume in one second 0." | 7.66 | Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema. ( Calverley, PM; Flenley, DC; Leggett, RJ, 1981) |
| "Clinical and physiologic data on chronic carbon monoxide poisoning are reviewed and the results of an investigation involving 7 garages in the Lausanne (Switzerland) area are reported." | 7.65 | [Risk of chronic carbon monoxide poisoning in automobile garages. Results of a study in the Lausanne region]. ( Köhl, U; Lob, M, 1975) |
| "Smokers with chronic obstructive pulmonary disease (COPD) have particular difficulty quitting." | 6.87 | Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial. ( Ellerbeck, EF; Fitzgerald, SA; Hutcheson, TD; Nollen, N; Phadnis, M; Richter, KP; Salzman, GA; Sharpe, MR; Vacek, J, 2018) |
| "There was increased mortality in interstitial lung disease‒PH as compared with chronic obstructive pulmonary disease‒PH, but PH severity based on the WHO classification did not alter survival." | 5.51 | Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide. ( Archer, SL; Misialek, JR; Prins, KW; Pritzker, M; Rose, L; Thenappan, T; Weir, EK, 2019) |
| "Fourteen patients with ischemic left ventricular dysfunction were studied with positron emission tomography, using oxygen-15-labeled water and carbon monoxide as tracers, and with contrast-enhanced MRI." | 5.15 | Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study. ( Beek, AM; Boellaard, R; Bondarenko, O; Knaapen, P; Lammertsma, AA; van Rossum, AC, 2011) |
| "Chimonin can reduce pulmonary hypertension and pulmonary vessel remodeling induced by hypoxic hypercapnia through inhibiting proliferation of collagen I, the mechanism maybe is up regulating endogenous carbon monoxide system." | 3.76 | [The effect of chimonin on collagen metabolism of pulmonary arterioles in chronic hypoxic rats]. ( Huang, XY; Qian, GQ; Wang, LX; Xu, XM, 2010) |
| "We investigated the association between chronic carbon monoxide (CO) exposure and electrocardiographic maximum/minimum P-wave duration (Pmax/Pmin), P-wave dispersion (Pd), maximum/minimum QT interval (QTmax/QTmin), and QT and corrected QT dispersion (QTd/cQTd), which are known as predictors of atrial fibrillation, ventricular arrhythmias, and sudden death." | 3.74 | Chronic carbon monoxide exposure increases electrocardiographic P-wave and QT dispersion. ( Aksoy, M; Davutoglu, V; Ozer, O; Sari, I; Yildirim, C; Zengin, S, 2008) |
| " In multivariate analysis, chronic graft-versus-host disease (relative risk, 16) and pretransplantation diffusion capacity for carbon monoxide or forced expiratory volume in the first second <80% predicted were independently associated with a late decrease in PF from baseline (relative risk, 7)." | 3.73 | Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. ( Barrett, AJ; Childs, R; Karimpour, S; Mielke, S; Montero, A; Rezvani, K; Savani, BN; Shenoy, A; Singh, A; Srinivasan, R, 2006) |
| " This study was designed to evaluate the effect of body position on diffusing capacity for carbon monoxide (DLco), Dm and Vc in male patients with chronic bronchitis and pulmonary emphysema." | 3.70 | Body position, membrane diffusing capacity and pulmonary capillary blood volume in chronic bronchitis and pulmonary emphysema. ( Chang, HI; Chang, SC; Chou, KC; Shiao, GM, 1999) |
| "To examine the pattern of immunoglobulins and cellular constituents in bronchoalveolar lavage fluid obtained from patients with sulfur mustard gas-induced asthma or chronic bronchitis as compared with healthy control subjects." | 3.70 | Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis. ( Emad, A; Rezaian, GR, 1999) |
| "The effects of carbon monoxide on exercise tolerance as assessed by the distance walked in 12 minutes were studied in 15 patients with severe chronic bronchitis and emphysema (mean forced expiratory volume in one second 0." | 3.66 | Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema. ( Calverley, PM; Flenley, DC; Leggett, RJ, 1981) |
| "Clinical and physiologic data on chronic carbon monoxide poisoning are reviewed and the results of an investigation involving 7 garages in the Lausanne (Switzerland) area are reported." | 3.65 | [Risk of chronic carbon monoxide poisoning in automobile garages. Results of a study in the Lausanne region]. ( Köhl, U; Lob, M, 1975) |
| "Smokers with chronic obstructive pulmonary disease (COPD) have particular difficulty quitting." | 2.87 | Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial. ( Ellerbeck, EF; Fitzgerald, SA; Hutcheson, TD; Nollen, N; Phadnis, M; Richter, KP; Salzman, GA; Sharpe, MR; Vacek, J, 2018) |
| "A double-blind, Latin-square, placebo-controlled, dose-response study was conducted in an inpatient general clinical research center and clinical pharmacology unit of a university teaching hospital." | 2.68 | Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users. ( Becker, PM; Jasinski, DR; Preston, KL; Sullivan, JT; Testa, MP; Wigely, FM; Wise, RA, 1997) |
| "Current invasive measures of pulmonary inflammation include markers in blood and airway effluent, with the cellular composition of tracheal fluid being the "gold standard"." | 2.43 | Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease? ( Andersen, CC; Harrison, CM, 2005) |
| "Leflunomide treatment was associated with significant gastrointestinal and other adverse effects leading 40% of patients to discontinue therapy." | 1.56 | Use of leflunomide in patients with chronic hypersensitivity pneumonitis. ( Culver, DA; Li, M; Noh, S; Pande, A; Sahoo, D; Wang, X; Yadav, R, 2020) |
| "Higher MELD-Na score, hepatic encephalopathy, impaired DLCO, clubbing, and spider naevi were independently associated with HPS." | 1.56 | Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease. ( Joshi, S; Kanala, JR; Kareem, H; Khiangte, B; Kothakota, SR; Kumar C, P; Kumar, VV; Nair, AK; Sasidharan, M, 2020) |
| "There was increased mortality in interstitial lung disease‒PH as compared with chronic obstructive pulmonary disease‒PH, but PH severity based on the WHO classification did not alter survival." | 1.51 | Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide. ( Archer, SL; Misialek, JR; Prins, KW; Pritzker, M; Rose, L; Thenappan, T; Weir, EK, 2019) |
| "The treatment of chronic hypersensitivity pneumonitis (cHP) often includes systemic oral corticosteroids, but the optimal pharmacologic management remains unclear." | 1.46 | Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. ( Aravena, C; Collard, HR; Dubé, BP; Elicker, BM; Fell, CD; Johannson, KA; Jones, KD; Ley, B; Manganas, H; Morisset, J; Ryerson, CJ; Vittinghoff, E; Wolters, PJ, 2017) |
| "Idiopathic chronic eosinophilic pneumonia was confirmed after exclusion of other causes of eosinophilic pneumonia and systemic disease." | 1.39 | Chronic eosinophilic pneumonia with persistent decreased diffusing capacity for carbon monoxide. ( Albertini, M; Blanc, S; Giovannini-Chami, L; Leroy, S, 2013) |
| "All subjects received periodontal treatment and smoking cessation advice as part of an individual, patient-based programme provided by dental hygienists trained in smoking cessation counselling." | 1.33 | Smoking cessation advice for patients with chronic periodontitis. ( Heasman, L; Heasman, PA; Nasry, HA; Preshaw, PM; Stacey, F; Swan, M, 2006) |
| "Carbon monoxide treatment was achieved by a new pharmacological approach in transplantation using methylene chloride (MC), which releases CO after degradation." | 1.31 | Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. ( Anegon, I; Bouchet, D; Braudeau, C; Buelow, R; Chauveau, C; Iyer, S; Mathieu, P; Renaudin, K; Roussel, JC; Soulillou, JP; Tesson, L, 2002) |
| "To define the relationship between hypoxemia and VCO/VCO2 deficit." | 1.31 | [Pulmonary circulatory amputation in chronic respiratory insufficiency. Simple, anodyne, and fast evaluation]. ( Bréant, J; Fleury, MF, 2001) |
| "However, proteinuria was the only significant independent predictor of DLCO/VA." | 1.30 | Reduction of diffusion capacity for carbon monoxide in diabetic patients. ( Car, N; Drazić, Z; Ljubić, S; Metelko, Z; Roglić, G, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 55 (48.25) | 18.7374 |
| 1990's | 15 (13.16) | 18.2507 |
| 2000's | 27 (23.68) | 29.6817 |
| 2010's | 12 (10.53) | 24.3611 |
| 2020's | 5 (4.39) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlgrim, C | 2 |
| Birkner, P | 2 |
| Seiler, F | 2 |
| Grundmann, S | 2 |
| Bode, C | 2 |
| Pottgiesser, T | 2 |
| Schoechlin, S | 1 |
| Fiddler, CA | 1 |
| Simler, N | 1 |
| Thillai, M | 1 |
| Parfrey, H | 1 |
| Rylance, S | 1 |
| Nightingale, R | 1 |
| Naunje, A | 1 |
| Mbalume, F | 1 |
| Jewell, C | 1 |
| Balmes, JR | 1 |
| Grigg, J | 1 |
| Mortimer, K | 1 |
| Wachsmuth, N | 1 |
| Soria, R | 1 |
| Jimenez, J | 1 |
| Schmidt, W | 1 |
| Terras Alexandre, A | 1 |
| Martins, N | 1 |
| Raimundo, S | 1 |
| Melo, N | 1 |
| Catetano Mota, P | 1 |
| Novais E Bastos, H | 1 |
| Pereira, JM | 1 |
| Cunha, R | 1 |
| Guimarães, S | 1 |
| Souto Moura, C | 1 |
| Morais, A | 1 |
| Noh, S | 1 |
| Yadav, R | 1 |
| Li, M | 1 |
| Wang, X | 1 |
| Sahoo, D | 1 |
| Culver, DA | 1 |
| Pande, A | 1 |
| Khiangte, B | 1 |
| Kothakota, SR | 1 |
| Sasidharan, M | 1 |
| Kareem, H | 1 |
| Joshi, S | 1 |
| Kumar, VV | 1 |
| Kanala, JR | 1 |
| Kumar C, P | 1 |
| Nair, AK | 1 |
| Rose, L | 1 |
| Prins, KW | 1 |
| Archer, SL | 1 |
| Pritzker, M | 1 |
| Weir, EK | 1 |
| Misialek, JR | 1 |
| Thenappan, T | 1 |
| Ellerbeck, EF | 1 |
| Nollen, N | 1 |
| Hutcheson, TD | 1 |
| Phadnis, M | 1 |
| Fitzgerald, SA | 1 |
| Vacek, J | 1 |
| Sharpe, MR | 1 |
| Salzman, GA | 1 |
| Richter, KP | 1 |
| Blanc, S | 1 |
| Albertini, M | 1 |
| Leroy, S | 1 |
| Giovannini-Chami, L | 1 |
| Nielsen, VG | 1 |
| Kulin, W | 1 |
| LaWall, JS | 1 |
| MacFarland, FN | 1 |
| Chen, A | 1 |
| Hadley, HA | 1 |
| DaDeppo, AJ | 1 |
| Steinbrenner, EB | 1 |
| Matika, RW | 1 |
| Morisset, J | 1 |
| Johannson, KA | 1 |
| Vittinghoff, E | 1 |
| Aravena, C | 1 |
| Elicker, BM | 1 |
| Jones, KD | 1 |
| Fell, CD | 1 |
| Manganas, H | 1 |
| Dubé, BP | 1 |
| Wolters, PJ | 1 |
| Collard, HR | 1 |
| Ryerson, CJ | 1 |
| Ley, B | 1 |
| Sari, I | 1 |
| Zengin, S | 1 |
| Ozer, O | 1 |
| Davutoglu, V | 1 |
| Yildirim, C | 1 |
| Aksoy, M | 1 |
| Roulaud, M | 1 |
| Donal, E | 1 |
| Raud-Raynier, P | 1 |
| Denjean, A | 1 |
| de Bisschop, C | 1 |
| Nakao, A | 1 |
| Faleo, G | 1 |
| Nalesnik, MA | 1 |
| Seda-Neto, J | 1 |
| Kohmoto, J | 1 |
| Murase, N | 1 |
| Funauchi, M | 1 |
| Kishimoto, K | 1 |
| Kinoshita, K | 1 |
| Wang, G | 1 |
| Hamid, T | 1 |
| Keith, RJ | 1 |
| Zhou, G | 1 |
| Partridge, CR | 1 |
| Xiang, X | 1 |
| Kingery, JR | 1 |
| Lewis, RK | 1 |
| Li, Q | 1 |
| Rokosh, DG | 1 |
| Ford, R | 1 |
| Spinale, FG | 1 |
| Riggs, DW | 1 |
| Srivastava, S | 1 |
| Bhatnagar, A | 1 |
| Bolli, R | 1 |
| Prabhu, SD | 1 |
| Huang, XY | 1 |
| Xu, XM | 1 |
| Qian, GQ | 1 |
| Wang, LX | 1 |
| Bondarenko, O | 2 |
| Knaapen, P | 2 |
| Beek, AM | 2 |
| Boellaard, R | 2 |
| Lammertsma, AA | 2 |
| van Rossum, AC | 2 |
| Kar-Purkayastha, I | 1 |
| Finlay, S | 1 |
| Murray, V | 1 |
| Mohamed, R | 1 |
| Freeman, JW | 1 |
| Guest, PJ | 1 |
| Davies, MK | 1 |
| Neuberger, JM | 1 |
| Chauveau, C | 1 |
| Bouchet, D | 1 |
| Roussel, JC | 1 |
| Mathieu, P | 1 |
| Braudeau, C | 1 |
| Renaudin, K | 1 |
| Tesson, L | 1 |
| Soulillou, JP | 1 |
| Iyer, S | 1 |
| Buelow, R | 1 |
| Anegon, I | 1 |
| Christensen, CC | 1 |
| Ryg, MS | 1 |
| Refvem, OK | 1 |
| Skjønsberg, OH | 1 |
| Mathieu-Nolf, M | 1 |
| Agostoni, PG | 1 |
| Bussotti, M | 1 |
| Palermo, P | 1 |
| Guazzi, M | 1 |
| BOURGUIGNON, G | 1 |
| TRUHAUT, R | 1 |
| DAKAK, M | 1 |
| LOB, M | 2 |
| MULLER, A | 1 |
| SAPIN-JALOUSTRE, H | 1 |
| GARBAGNI, R | 1 |
| CARELLI, E | 1 |
| RANDOWA, D | 1 |
| SIERAWSKI, S | 1 |
| Lassinger, BK | 1 |
| Kwak, C | 1 |
| Walford, RL | 1 |
| Jankovic, J | 1 |
| Rutherford, RM | 1 |
| Brutsche, MH | 1 |
| Kearns, M | 1 |
| Bourke, M | 1 |
| Stevens, F | 1 |
| Gilmartin, JJ | 1 |
| Harrison, CM | 1 |
| Andersen, CC | 1 |
| Dubuis, E | 1 |
| Potier, M | 1 |
| Wang, R | 1 |
| Vandier, C | 1 |
| van Dockum, WG | 1 |
| Kok, WE | 1 |
| Götte, MJ | 1 |
| Visser, CA | 1 |
| Visser, FC | 1 |
| Vitali, SH | 1 |
| Mitsialis, SA | 1 |
| Christou, H | 1 |
| Fernandez-Gonzalez, A | 1 |
| Liu, X | 1 |
| Kourembanas, S | 1 |
| Iwakiri, Y | 1 |
| Groszmann, RJ | 1 |
| Nasry, HA | 1 |
| Preshaw, PM | 1 |
| Stacey, F | 1 |
| Heasman, L | 1 |
| Swan, M | 1 |
| Heasman, PA | 1 |
| Mitlyng, BL | 1 |
| Singh, JA | 1 |
| Furne, JK | 1 |
| Ruddy, J | 1 |
| Levitt, MD | 1 |
| Forastiere, F | 1 |
| Stafoggia, M | 1 |
| Tasco, C | 1 |
| Picciotto, S | 1 |
| Agabiti, N | 1 |
| Cesaroni, G | 1 |
| Perucci, CA | 1 |
| Krediet, TG | 1 |
| Cirkel, GA | 1 |
| Vreman, HJ | 2 |
| Wong, RJ | 1 |
| Stevenson, DK | 2 |
| Groenendaal, F | 1 |
| Egberts, J | 1 |
| Van Bel, F | 1 |
| Savani, BN | 1 |
| Montero, A | 1 |
| Srinivasan, R | 1 |
| Singh, A | 1 |
| Shenoy, A | 1 |
| Mielke, S | 1 |
| Rezvani, K | 1 |
| Karimpour, S | 1 |
| Childs, R | 1 |
| Barrett, AJ | 1 |
| Cançado, JE | 1 |
| Braga, A | 1 |
| Pereira, LA | 1 |
| Arbex, MA | 1 |
| Saldiva, PH | 1 |
| Santos, Ude P | 1 |
| Gullu, H | 1 |
| Caliskan, M | 1 |
| Ciftci, O | 1 |
| Erdogan, D | 1 |
| Topcu, S | 1 |
| Yildirim, E | 1 |
| Yildirir, A | 1 |
| Muderrisoglu, H | 1 |
| Kim, TS | 1 |
| Kim, DJ | 1 |
| Lee, H | 1 |
| Kim, YK | 1 |
| James, F | 1 |
| Rumble, L | 1 |
| Pappenheimer, JR | 1 |
| Calverley, PM | 1 |
| Leggett, RJ | 1 |
| Flenley, DC | 1 |
| Dhindsa, DS | 1 |
| Ochsner, AJ | 1 |
| Borst, JR | 1 |
| Claude, JR | 1 |
| Efthymiou, ML | 1 |
| Thunedborg, P | 1 |
| Nielsen, AL | 1 |
| Brinkenfeldt, H | 1 |
| Brahm, J | 1 |
| Jensen, HA | 1 |
| Bréant, J | 2 |
| Fleury, MF | 2 |
| Goudin, J | 1 |
| Bance, N | 1 |
| Thorpe, M | 1 |
| Mahoney, JJ | 1 |
| Sullivan, JT | 1 |
| Becker, PM | 1 |
| Preston, KL | 1 |
| Wise, RA | 1 |
| Wigely, FM | 1 |
| Testa, MP | 1 |
| Jasinski, DR | 1 |
| Emad, A | 2 |
| Rezaian, GR | 2 |
| Yamauchi, H | 1 |
| Fukuyama, H | 1 |
| Nagahama, Y | 1 |
| Katsumi, Y | 1 |
| Okazawa, H | 1 |
| Long, W | 1 |
| Tate, RB | 1 |
| Neuman, M | 1 |
| Manfreda, J | 1 |
| Becker, AB | 1 |
| Anthonisen, NR | 1 |
| Ljubić, S | 1 |
| Metelko, Z | 1 |
| Car, N | 1 |
| Roglić, G | 1 |
| Drazić, Z | 1 |
| Chou, KC | 1 |
| Chang, SC | 1 |
| Chang, HI | 1 |
| Shiao, GM | 1 |
| Woehlck, HJ | 1 |
| Connolly, LA | 1 |
| Cinquegrani, MP | 1 |
| Dunning, MB | 1 |
| Hoffmann, RG | 1 |
| Di Giulio, C | 1 |
| Grilli, A | 1 |
| Ciocca, I | 1 |
| Macrì, MA | 1 |
| Daniele, F | 1 |
| Sabatino, G | 1 |
| Cacchio, M | 1 |
| De Lutiis, MA | 1 |
| Da Porto, R | 1 |
| Di Natale, F | 1 |
| Felaco, M | 1 |
| O'Donaughy, TL | 1 |
| Walker, BR | 1 |
| Köhl, U | 1 |
| Patsch, J | 2 |
| McConn, R | 1 |
| Ribon, A | 1 |
| Perera, S | 1 |
| Gavencak, J | 1 |
| Magnussen, H | 1 |
| Holle, JP | 1 |
| Hartmann, V | 1 |
| Schoenen, JD | 1 |
| Hebbel, RP | 1 |
| Eaton, JW | 1 |
| Modler, S | 1 |
| Jacob, HS | 1 |
| Sassa, S | 1 |
| Kappas, A | 1 |
| Bernstein, SE | 1 |
| Alvares, AP | 1 |
| Cordasco, EM | 1 |
| VanOrdstrand, HS | 1 |
| Vanuxem, D | 1 |
| Guillot, C | 1 |
| Fornaris, E | 1 |
| Weiller, PJ | 1 |
| Grimaud, C | 1 |
| Newth, CJ | 1 |
| Cotton, DJ | 1 |
| Nadel, JA | 1 |
| Zorn, H | 2 |
| Benatar, SR | 1 |
| Clark, TJ | 1 |
| Cochrane, GM | 1 |
| Dueva, LA | 1 |
| Tolmachev, DA | 1 |
| Volkova, AP | 1 |
| Mitacek, EJ | 1 |
| Brunnemann, KD | 1 |
| Polednak, AP | 1 |
| Hoffmann, D | 1 |
| Suttajit, M | 1 |
| Moinard, J | 1 |
| Guenard, H | 1 |
| Pham, QT | 3 |
| Mur, JM | 1 |
| Teculescu, D | 1 |
| Chau, N | 1 |
| Gabiano, M | 1 |
| Gaertner, M | 1 |
| Henquel, JC | 1 |
| Sirota, AD | 1 |
| Curran, JP | 1 |
| Habif, V | 1 |
| Anderhub, HP | 1 |
| Hofer, P | 1 |
| Scherrer, M | 1 |
| Franks, H | 1 |
| Uffholtz, H | 1 |
| Schrijen, F | 1 |
| Boushy, SF | 1 |
| Lüderitz, P | 1 |
| Burrows, B | 1 |
| Weiss, EB | 1 |
| Desforges, JF | 1 |
| Reinert, M | 1 |
| Trendelenburg, F | 1 |
| Schmidt, F | 1 |
| Lopez-Majano, V | 1 |
| Dutton, RE | 1 |
| Banner, AS | 1 |
| Uzawa, T | 1 |
| Osada, H | 1 |
| Isoyama, Y | 1 |
| Nonaka, T | 1 |
| Tajima, G | 1 |
| Myre, M | 1 |
| Martin, J | 1 |
| Knelson, J | 1 |
| Graimprey, J | 1 |
| Jain, BP | 1 |
| Pande, JN | 1 |
| Guleria, JS | 1 |
| Muldoon, BC | 1 |
| Turner-Warwick, M | 1 |
| Cabal, C | 1 |
| Kanagami, H | 1 |
| Nagashima, T | 1 |
| Saito, T | 1 |
| Lacoste, J | 1 |
| Regan, GM | 1 |
| Tagg, B | 1 |
| Walford, J | 1 |
| Thomson, ML | 1 |
| Saidel, GM | 1 |
| Militano, TC | 1 |
| Chester, EH | 1 |
| Vandenbergh, E | 1 |
| Billiet, L | 1 |
| Van de Woestijne, KP | 1 |
| Gyselen, A | 1 |
| Gabriel, S | 1 |
| Palmer, KN | 1 |
| Diament, ML | 1 |
| Kreukniet, J | 1 |
| Bilchik, RC | 1 |
| Muller-Bergh, HA | 1 |
| Freshman, ME | 1 |
| Mitchell, MM | 1 |
| Renzetti, AD | 1 |
| Goldsmith, JR | 1 |
| Ciuhandu, G | 1 |
| Rusu, V | 1 |
| Diaconovici, M | 1 |
| Kiss, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers[NCT02148445] | Phase 3 | 398 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension Compared to Male Cirrhosis Patients Without Hypotension[NCT05051293] | 0 participants (Actual) | Observational | 2021-08-22 | Withdrawn (stopped due to Study will be changed from prospective to retrospective) | |||
| Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans Syndrome[NCT01287078] | Phase 2 | 25 participants (Actual) | Interventional | 2011-01-29 | Completed | ||
| The Effectiveness of Rhinopharyngeal Retrograde Clearance on the Upper Airways Symptomatology and Function in Adults[NCT01976039] | 24 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change in respiratory function, as measured by spirometry (FEV1), at 12 months post-randomization. (NCT02148445)
Timeframe: Month 12
| Intervention | % of predicted (Mean) |
|---|---|
| Standard Smoking Cessation | 55.4 |
| Extended Nicotine Replacement Therapy | 56.8 |
7-day point prevalent abstinence at 12 months, confirmed by exhaled CO <=10 (NCT02148445)
Timeframe: Month 12
| Intervention | Participants (Count of Participants) |
|---|---|
| Standard Smoking Cessation | 23 |
| Extended Nicotine Replacement Therapy | 24 |
"6 month sustained abstinence as measured by self-report at 6 and 12 months and confirmed by CO at 6 and 12 months. Participants who were confirmed as non-smokers by carbon monoxide (CO) at both Month 6 and Month 12 were considered to have 6-month sustained abstinence." (NCT02148445)
Timeframe: Month 6 through Month 12
| Intervention | Participants (Count of Participants) |
|---|---|
| Standard Smoking Cessation | 15 |
| Extended Nicotine Replacement Therapy | 12 |
"Self-reported and biochemically verified 7-day abstinence. Participants were asked at Month 3, Month 6, and Month 12, Have you smoked any cigarettes or little cigars, even a puff, in the past 7 days? They also completed an exhaled carbon monoxide lab test at Month 3, 6 and 12. Biochemical verification= exhaled CO <=10 ppm. Month 12 biochemically verified abstinence is the primary outcome, and is not reported in this table." (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Month 3, self-report | Month 3, biochemically verified | Month 6, self-report | Month 6, biochemically verified | Month 12, self-report | |
| Extended Nicotine Replacement Therapy | 16 | 14 | 20 | 19 | 28 |
| Standard Smoking Cessation | 27 | 25 | 28 | 25 | 25 |
"Average number of cigarettes per day over one year. Participants were asked at Month 3, Month 6, and Month 12 During the past 7 days, on those days that you smoked, what was the average number of cigarettes or little cigars smoked per day?" (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | cigarettes per day (Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 10.5 | 9.1 | 8.1 |
| Standard Smoking Cessation | 7.9 | 8.1 | 8.5 |
"Average number of cigarettes per day over one year, among continued smokers. All participants were asked During the past 7 days, on those days that you smoked, what was the average number of cigarettes smoked per day? at Month 3, Month 6, and Month 12. This analysis looks at the number of cigarettes per day among participants who were still smoking." (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | cigarettes per day (Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 11.4 | 9.9 | 9.3 |
| Standard Smoking Cessation | 8.7 | 9.1 | 9.7 |
Carbon monoxide (CO) exposure over 12 months. At Month 3, Month 6, and Month 12, participants completed an expired carbon monoxide laboratory test, which measured CO in parts per million. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | parts per million (ppm) (Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 17.4 | 15.4 | 13.8 |
| Standard Smoking Cessation | 15.0 | 14.6 | 15.5 |
Carbon monoxide (CO) exposure over 12 months. At Month 3, Month 6, and Month 12, participants completed an expired carbon monoxide laboratory test, which measured CO in parts per million. This analysis looks at CO among those continuing to smoke. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | parts per million (ppm) (Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 18.8 | 17.0 | 15.8 |
| Standard Smoking Cessation | 16.4 | 16.0 | 17.4 |
Creatinine-adjusted NNAL (4-(methylnitrosamino)-1-(3)pyridyl-1-butanol)) exposure over 12 months. At Month 3, Month 6, and Month 12, participants provided a urine sample that was used to assess their level of urinary creatinine and NNAL. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | pg/mg creatinine (Geometric Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 320.1 | 186.0 | 183.5 |
| Standard Smoking Cessation | 279.0 | 178.2 | 190.4 |
Creatinine-adjusted NNAL (4-(methylnitrosamino)-1-(3)pyridyl-1-butanol)) exposure over 12 months. At Month 3, Month 6, and Month 12, participants provided a urine sample that was used to assess their level of urinary creatinine and NNAL. This analysis looks at NNAL among continuing smokers only. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | pg/mg creatinine (Geometric Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 337.6 | 217.1 | 247.5 |
| Standard Smoking Cessation | 314.6 | 219.8 | 257.0 |
Cotinine over 12 months, adjusted for creatinine. At Month 3, Month 6, and Month 12, participants provided a urine sample that was used to assess their level of urinary creatinine and cotinine. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | ng/mg creatinine (Geometric Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 3378.1 | 3342.3 | 2363.7 |
| Standard Smoking Cessation | 2652.5 | 2390.7 | 2159.0 |
Cotinine over 12 months, adjusted for creatinine. At Month 3, Month 6, and Month 12, participants provided a urine sample that was used to assess their level of urinary creatinine and cotinine. This analysis looks at NNAL among continuing smokers only. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | ng/mg creatinine (Geometric Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 3305.8 | 3502.2 | 2782.7 |
| Standard Smoking Cessation | 2771.2 | 2850.7 | 2733.9 |
Number of self-reported quit attempts over one year. At Month 3 and Month 6, participants reported the number of quit attempts in the last 3 months. At Month 12, participants reported the number of quit attempts in the last 6 months. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | number of quit attempts (Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 3.7 | 4.8 | 6.2 |
| Standard Smoking Cessation | 4.6 | 4.5 | 5.7 |
Respiratory symptoms as measured by the COPD Assessment Test (CAT) respiratory questionnaire. Participants completed this 8-item assessment at Month 3, Month 6, and Month 12. Scores range from 0 to 40, with higher levels indicating higher impact of COPD on well-being and daily life. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Month 3 | Month 6 | Month 12 | |
| Extended Nicotine Replacement Therapy | 19.3 | 18.1 | 18.2 |
| Standard Smoking Cessation | 17.8 | 17.9 | 17.5 |
Number of cardiac-related hospital admissions and emergency room visits. Participants were asked how many times they had visited the ED or were admitted to the hospital for cardiac-related problems at Month 3, Month 6, and Month 12. (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | Participants (Count of Participants) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Month 371962791 | Month 371962792 | Month 671962791 | Month 671962792 | Month 1271962791 | Month 1271962792 | |||||||||||||
| 0 Visits | 2 or more Visits | 1 Visit | ||||||||||||||||
| Standard Smoking Cessation | 181 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 185 | |||||||||||||||||
| Standard Smoking Cessation | 7 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 6 | |||||||||||||||||
| Standard Smoking Cessation | 1 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 0 | |||||||||||||||||
| Standard Smoking Cessation | 171 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 180 | |||||||||||||||||
| Standard Smoking Cessation | 10 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 4 | |||||||||||||||||
| Standard Smoking Cessation | 0 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 1 | |||||||||||||||||
| Standard Smoking Cessation | 175 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 167 | |||||||||||||||||
| Standard Smoking Cessation | 8 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 12 | |||||||||||||||||
| Standard Smoking Cessation | 2 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 3 | |||||||||||||||||
Number of respiratory-related hospital admissions and emergency room visits. Participants were asked how many times they had visited the ED or were admitted to the hospital for respiratory-related problems at Month 3, Month 6, and Month 12 (NCT02148445)
Timeframe: Month 3, Month 6, Month 12
| Intervention | Participants (Count of Participants) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Month 371962791 | Month 371962792 | Month 671962792 | Month 671962791 | Month 1271962791 | Month 1271962792 | |||||||||||||
| 0 Visits | 1 Visit | 2 or more Visits | ||||||||||||||||
| Standard Smoking Cessation | 176 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 169 | |||||||||||||||||
| Standard Smoking Cessation | 11 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 15 | |||||||||||||||||
| Standard Smoking Cessation | 2 | |||||||||||||||||
| Standard Smoking Cessation | 152 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 154 | |||||||||||||||||
| Standard Smoking Cessation | 22 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 24 | |||||||||||||||||
| Standard Smoking Cessation | 7 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 7 | |||||||||||||||||
| Standard Smoking Cessation | 157 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 153 | |||||||||||||||||
| Standard Smoking Cessation | 18 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 20 | |||||||||||||||||
| Standard Smoking Cessation | 10 | |||||||||||||||||
| Extended Nicotine Replacement Therapy | 10 | |||||||||||||||||
Participants with progressive disease at baseline with decline in FEV1 greater than 10% (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 2 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with progressive disease at baseline with stablization of FEV1 (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 2 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with stable disease at baseline with stablization in FEV1 and greater than 25% decline in systemic immunosuppression (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 3 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants who did not respond to treatment with cyclosporine inhalation solution (CIS) (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 7 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 2 |
Participants who responded to treatment with cyclosporine inhalation solution (CIS) (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 9 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with stable disease at baseline with stablization of FEV1 and no change or increase in systemic immunosuppresion (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 4 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 2 |
Participants with stable or progressive disease at baseline with greater than 20% of decline in FEV1 (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 1 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with stable or progressive disease at baseline with improvement of FEV1 (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 4 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
10 reviews available for carbon monoxide and Chronic Illness
| Article | Year |
|---|---|
[Early diagnosis of connective tissue disease-related pulmonary hypertension].
Topics: Biomarkers; Carbon Monoxide; Chronic Disease; Connective Tissue Diseases; Early Diagnosis; Echocardi | 2009 |
Poisons in the air: a cause of chronic disease in children.
Topics: Air Pollutants; Carbon Monoxide; Child; Child Welfare; Chronic Disease; Female; Fetus; Humans; Nitro | 2002 |
Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?
Topics: Biomarkers; Breath Tests; Carbon Monoxide; Chronic Disease; Humans; Hydrocarbons; Infant, Newborn; I | 2005 |
The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.
Topics: Adrenomedullin; Animals; Biological Factors; Blood Pressure; Cannabinoid Receptor Modulators; Carbon | 2006 |
[Clinical repercussions of exposure to atmospheric pollution].
Topics: Air Pollutants; Air Pollution; Brazil; Carbon Monoxide; Cardiovascular Diseases; Chronic Disease; En | 2006 |
Carbon monoxide and carboxyhemoglobin.
Topics: Acute Disease; Adult; Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Child; Chronic | 1995 |
Air pollution: its effects on health and respiratory disease--a review.
Topics: Air Pollution; Asthma; Bronchitis; Carbon Monoxide; Chronic Disease; Hydrocarbons; Meteorological Co | 1977 |
[Chronic carbon monoxide poisoning].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Chronic Disease; Environmental Exposu | 1975 |
[Demonstrable effects of carbon monoxide on the human organism].
Topics: Carbon Dioxide; Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Cardiovascular System | 1972 |
Arterial oxygenation and pulmonary hemodynamics in patients with chronic airways obstruction.
Topics: Blood Pressure; Carbon Monoxide; Cardiac Output; Chronic Disease; Hemodynamics; Humans; Hypertension | 1974 |
7 trials available for carbon monoxide and Chronic Illness
| Article | Year |
|---|---|
Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Counseling; Female; Humans; Lung Diseases; Male; Midd | 2018 |
Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study.
Topics: Aged; Antimetabolites; Carbon Monoxide; Chronic Disease; Contrast Media; Female; Humans; Magnetic Re | 2011 |
Does lung diffusion impairment affect exercise capacity in patients with heart failure?
Topics: Blood Gas Analysis; Carbon Monoxide; Cardiac Output, Low; Chronic Disease; Exercise Test; Exercise T | 2002 |
Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases.
Topics: Aged; Aged, 80 and over; Anemia; Arthritis, Rheumatoid; Bone Marrow; Breath Tests; Carbon Monoxide; | 2006 |
Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation.
Topics: Adult; Brain-Derived Neurotrophic Factor; Carbon Monoxide; Chronic Disease; Enzyme-Linked Immunosorb | 2007 |
Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users.
Topics: Adult; Carbon Monoxide; Chronic Disease; Cocaine; Dose-Response Relationship, Drug; Double-Blind Met | 1997 |
[Measurement of global diffusion capacity for CO, membrane diffusion capacity for CO and capillary blood volume in patients with bronchial emphysema after fominoben HCl. Short- and long-time trials (author's transl)].
Topics: Adult; Blood Volume; Capillaries; Carbon Monoxide; Cell Membrane; Chronic Disease; Clinical Trials a | 1979 |
97 other studies available for carbon monoxide and Chronic Illness
| Article | Year |
|---|---|
Estimated plasma volume status is a modest predictor of true plasma volume excess in compensated chronic heart failure patients.
Topics: Aged; Anthropometry; Area Under Curve; Carbon Monoxide; Cardiology; Chronic Disease; Cross-Sectional | 2021 |
Clinically unrecognized plasma volume expansion predicts long-term all-cause-mortality in chronic heart failure.
Topics: Carbon Monoxide; Chronic Disease; Diuretics; Female; Heart Failure; Humans; Pilot Projects; Plasma V | 2022 |
Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience.
Topics: Adrenal Cortex Hormones; Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chroni | 2019 |
Lung health and exposure to air pollution in Malawian children (CAPS): a cross-sectional study.
Topics: Air Pollution, Indoor; Body Height; Body Weight; Carbon Monoxide; Carboxyhemoglobin; Child; Chronic | 2019 |
Modification of the CO-rebreathing method to determine haemoglobin mass and blood volume in patients suffering from chronic mountain sickness.
Topics: Administration, Inhalation; Adult; Aged; Altitude Sickness; Blood Volume; Carbon Monoxide; Chronic D | 2019 |
Impact of Azathioprine use in chronic hypersensitivity pneumonitis patients.
Topics: Adult; Aged; Aged, 80 and over; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chron | 2020 |
Use of leflunomide in patients with chronic hypersensitivity pneumonitis.
Topics: Adult; Aged; Alveolitis, Extrinsic Allergic; Carbon Monoxide; Chronic Disease; Female; Humans; Immun | 2020 |
Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease.
Topics: Carbon Monoxide; Chronic Disease; Cross-Sectional Studies; Female; Hepatic Encephalopathy; Hepatopul | 2020 |
Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
Topics: Aged; Carbon Monoxide; Chronic Disease; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; | 2019 |
Chronic eosinophilic pneumonia with persistent decreased diffusing capacity for carbon monoxide.
Topics: Adolescent; Bronchoalveolar Lavage Fluid; Carbon Monoxide; Chronic Disease; Diagnosis, Differential; | 2013 |
Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen.
Topics: Anticoagulants; Blood Coagulation; Body Mass Index; Carbon Monoxide; Chronic Disease; Citrates; Fema | 2015 |
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.
Topics: Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chronic Disease; Female; Glucoc | 2017 |
Chronic carbon monoxide exposure increases electrocardiographic P-wave and QT dispersion.
Topics: Adult; Air Pollutants, Occupational; Arrhythmias, Cardiac; Blood Pressure; Body Mass Index; Carbon M | 2008 |
Does exercise have deleterious consequences for the lungs of patients with chronic heart failure?
Topics: Aged; Analysis of Variance; Carbon Monoxide; Case-Control Studies; Chronic Disease; Contraindication | 2009 |
Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.
Topics: Animals; Atrophy; Carbon Monoxide; Chronic Disease; Disease Models, Animal; Disease Progression; Dos | 2009 |
Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.
Topics: Animals; Apoptosis; Carbon Monoxide; Cardiotonic Agents; Chronic Disease; Fibrosis; Gene Expression; | 2010 |
[The effect of chimonin on collagen metabolism of pulmonary arterioles in chronic hypoxic rats].
Topics: Animals; Arterioles; Carbon Monoxide; Chronic Disease; Collagen Type I; Collagen Type III; Drugs, Ch | 2010 |
Low-level exposure to carbon monoxide.
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Environmental Exposure; Humans | 2012 |
Pulmonary gas exchange abnormalities in liver transplant candidates.
Topics: Adolescent; Adult; Aged; Arteries; Carbon Dioxide; Carbon Monoxide; Chronic Disease; Female; Humans; | 2002 |
Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection.
Topics: Animals; Carbon Monoxide; Carboxyhemoglobin; Chlorocebus aethiops; Chronic Disease; COS Cells; Gene | 2002 |
Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease.
Topics: Adult; Aged; Atmospheric Pressure; Blood Gas Analysis; Carbon Dioxide; Carbon Monoxide; Chronic Dise | 2002 |
[Vestibular chronaxy in experimental chronic poisoning by carbon monoxide in the rabbit; comparison with chronic poisoning in man].
Topics: Animals; Carbon Monoxide; Carbon Monoxide Poisoning; Chronaxy; Chronic Disease; Ear, Inner; Humans; | 1955 |
[Dangers of fuel in the winter; case of chronic poisoning caused by carbon monoxide].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Humans; Poisoning; Seasons | 1956 |
[Chronic & mass poisoning by carbon monoxide].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Humans | 1957 |
[The pulmonary diffusion of CO in chronic lung diseases].
Topics: Carbon Monoxide; Chronic Disease; Humans; Lung Diseases; Pulmonary Diffusing Capacity; Respiration | 1961 |
[DETERMINATION OF THE DIFFUSION CAPACITY OF THE LUNG WITH AID OF CARBON MONOXIDE (SINGLE RESPIRATION METHOD) IN CHRONIC LUNG DISEASES].
Topics: Carbon Monoxide; Chronic Disease; Humans; Lung Diseases; Pneumonectomy; Respiratory Function Tests | 1964 |
Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity?
Topics: Aged; Brain; Carbon Monoxide; Chronic Disease; Gait; Humans; Hypoxia; Magnetic Resonance Imaging; Ma | 2004 |
HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients.
Topics: Adult; Biomarkers; Carbon Monoxide; Case-Control Studies; Chronic Disease; Female; Follow-Up Studies | 2004 |
Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels.
Topics: Animals; Calcium; Carbon Monoxide; Cell Polarity; Chronic Disease; Drug Administration Schedule; Hem | 2005 |
Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET.
Topics: Adult; Aged; Carbon Monoxide; Cardiomyopathy, Hypertrophic; Case-Control Studies; Chronic Disease; F | 2005 |
Mechanisms of heme oxygenase-1-mediated cardiac and pulmonary vascular protection in chronic hypoxia: roles of carbon monoxide and bilirubin.
Topics: Animals; Bilirubin; Biliverdine; Carbon Monoxide; Chronic Disease; Heme Oxygenase-1; Hypertension, P | 2005 |
Smoking cessation advice for patients with chronic periodontitis.
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Central Nervous System Stimulants; Chronic Disease; | 2006 |
Socioeconomic status, particulate air pollution, and daily mortality: differential exposure or differential susceptibility.
Topics: Adult; Air Pollutants; Air Pollution; Carbon Monoxide; Chronic Disease; Disease Susceptibility; Envi | 2007 |
End-tidal carbon monoxide measurements in infant respiratory distress syndrome.
Topics: Breath Tests; Carbon Monoxide; Chronic Disease; Humans; Infant, Newborn; Lung Diseases; Prognosis; R | 2006 |
Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.
Topics: Adolescent; Adult; Carbon Monoxide; Child; Chronic Disease; Comorbidity; Disease Progression; Female | 2006 |
Light cigarette smoking impairs coronary microvascular functions as severely as smoking regular cigarettes.
Topics: Acute Disease; Adult; Blood Flow Velocity; Carbon Monoxide; Chronic Disease; Coronary Circulation; C | 2007 |
Carbon monoxide diffusing studies in the clinical evaluation of chronic lung diseases.
Topics: Adolescent; Adult; Aged; Blood Gas Analysis; Carbon Dioxide; Carbon Monoxide; Chronic Disease; Femal | 1967 |
Hypoxic insomnia: effects of carbon monoxide and acclimatization.
Topics: Acclimatization; Altitude; Animals; Body Weight; Carbon Monoxide; Chronic Disease; Hemoglobins; Huma | 1984 |
Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema.
Topics: Bronchitis; Carbon Monoxide; Carboxyhemoglobin; Chronic Disease; Emphysema; Female; Humans; Male; Ph | 1981 |
Hemodynamic and metabolic effects of chronic carbon monoxide exposure in cynomolgus monkeys (Macaca fascicularis).
Topics: Animals; Carbon Dioxide; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Female; Hemody | 1981 |
[Chronic carbon monoxide poisoning].
Topics: Adult; Air Pollution; Carbon Monoxide; Carbon Monoxide Poisoning; Child; Child, Preschool; Chronic D | 1982 |
[Subacute and chronic occupational carbon monoxide poisoning].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Humans; Occupational Diseases | 1982 |
Carbon monoxide in chronic uraemia related to erythropoietin treatment and smoking habits.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Erythropoietin; Female; Humans; Longitudinal Studies; | 1995 |
[Gas exchange during spontaneous and controlled ventilation in obese subjects with chronic bronchitis. Value of normalized CO intake].
Topics: Adult; Aged; Blood Gas Analysis; Bronchitis; Carbon Monoxide; Chronic Disease; Female; Humans; Male; | 1993 |
Chronic carbon monoxide poisoning.
Topics: Adult; Brain Damage, Chronic; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Diagnosis | 1994 |
The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases.
Topics: Adult; Aged; Airway Obstruction; Asthma; Biopsy; Bronchiectasis; Bronchitis; Bronchoscopy; Carbon Mo | 1997 |
Cerebral hematocrit decreases with hemodynamic compromise in carotid artery occlusion: a PET study.
Topics: Aged; Brain; Brain Ischemia; Carbon Monoxide; Carotid Artery Diseases; Carotid Artery, Internal; Cer | 1998 |
Respiratory symptoms in a susceptible population due to burning of agricultural residue.
Topics: Adult; Agriculture; Air Pollutants; Air Pollution; Airway Obstruction; Asthma; Bronchial Hyperreacti | 1998 |
Reduction of diffusion capacity for carbon monoxide in diabetic patients.
Topics: Adult; Carbon Monoxide; Chromatography, Ion Exchange; Chronic Disease; Diabetes Complications; Diabe | 1998 |
Body position, membrane diffusing capacity and pulmonary capillary blood volume in chronic bronchitis and pulmonary emphysema.
Topics: Aged; Blood Volume; Bronchitis; Carbon Monoxide; Chronic Disease; Humans; Lung; Middle Aged; Posture | 1999 |
Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis.
Topics: Adult; Asthma; Bronchitis; Bronchoalveolar Lavage Fluid; Carbon Monoxide; Case-Control Studies; Chem | 1999 |
Acute smoking increases ST depression in humans during general anesthesia.
Topics: Acute Disease; Adult; Anesthesia, General; Anesthetics, Inhalation; Blood Pressure; Carbon Monoxide; | 1999 |
Carotid body NO-CO interaction and chronic hypoxia.
Topics: Animals; Carbon Monoxide; Carotid Body; Chemoreceptor Cells; Chronic Disease; Heme Oxygenase (Decycl | 2000 |
Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats.
Topics: Animals; Carbon Monoxide; Chronic Disease; Consciousness; Enzyme Inhibitors; Heme Oxygenase (Decycli | 2000 |
[Pulmonary circulatory amputation in chronic respiratory insufficiency. Simple, anodyne, and fast evaluation].
Topics: Aged; Carbon Dioxide; Carbon Monoxide; Chronic Disease; Female; Humans; Hypoxia; Lung; Male; Middle | 2001 |
[Risk of chronic carbon monoxide poisoning in automobile garages. Results of a study in the Lausanne region].
Topics: Air Pollution; Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Chronic Disease; Envir | 1975 |
The oxyhemoglobin dissociation curve in acute disease.
Topics: Acute Disease; Adenosine Triphosphate; Altitude; Blood Gas Analysis; Blood Preservation; Carbon Diox | 1975 |
Dco at various breath-holding times: comparison in patients with chronic bronchial asthma and emphysema.
Topics: Adult; Asthma; Carbon Monoxide; Chronic Disease; Humans; Lung; Middle Aged; Pulmonary Diffusing Capa | 1979 |
Extreme but asymptomatic carboxyhemoglobinemia and chronic lung disease.
Topics: Aged; Carbon Monoxide; Carboxyhemoglobin; Chronic Disease; Hemoglobins; Humans; Hypoxia; Lung Diseas | 1978 |
Heme biosynthesis and drug metabolism in mice with hereditary hemolytic anemia. Heme oxygenase induction as an adaptive response for maintaining cytochrome P-450 in chronic hemolysis.
Topics: Anemia, Hemolytic, Congenital; Animals; Carbon Monoxide; Chronic Disease; Cytochrome P-450 Enzyme Sy | 1979 |
Air pollution and COPD.
Topics: Air Pollutants; Cadmium; Carbon Monoxide; Chlorine; Chronic Disease; Humans; Lung; Lung Diseases, Ob | 1977 |
Secondary polycythaemia in chronic respiratory insufficiency.
Topics: Carbon Monoxide; Chronic Disease; Diphosphoglyceric Acids; Erythrocytes; Hemoglobins; Humans; Oxygen | 1977 |
[Pulmonary diffusing capacity for carbon monoxide during rest and following exertion in chronic obstructive ephysema].
Topics: Carbon Monoxide; Chronic Disease; Emphysema; Humans; Physical Exertion; Pulmonary Alveoli; Pulmonary | 1977 |
Pulmonary diffusing capacity measured at multiple intervals during a single exhalation in man.
Topics: Adult; Asthma; Blood Volume; Carbon Monoxide; Chronic Disease; Humans; Lung Diseases, Obstructive; M | 1977 |
Clinical relevance of the flow rate response to low density gas breathing in asthmatics.
Topics: Acute Disease; Adolescent; Adult; Aged; Airway Obstruction; Asthma; Bronchodilator Agents; Carbon Mo | 1975 |
[Cellular immunity indices in combined chronic exposure to stress and low concentrations of carbon monoxide (II). Experimental research].
Topics: Animals; Carbon Monoxide; Chronic Disease; Dose-Response Relationship, Drug; Immunity, Cellular; Imm | 1992 |
Composition of popular tobacco products in Thailand, and its relevance to disease prevention.
Topics: Advertising; Carbon Monoxide; Chronic Disease; Coal Tar; Evaluation Studies as Topic; Filtration; Hu | 1991 |
Determination of lung capillary blood volume and membrane diffusing capacity in patients with COLD using the NO-CO method.
Topics: Adult; Aged; Blood Volume Determination; Capillary Permeability; Carbon Monoxide; Chronic Disease; F | 1990 |
A longitudinal study of symptoms and respiratory function tests in iron miners.
Topics: Adult; Asthma; Bronchitis; Carbon Monoxide; Chronic Disease; France; Health; Health Status; Humans; | 1986 |
Smoking cessation in chronically ill medical patients.
Topics: Behavior Therapy; Carbon Monoxide; Chronic Disease; Coronary Disease; Feedback; Follow-Up Studies; H | 1985 |
[Normal values of Hb-CO saturation of blood].
Topics: Adult; Age Factors; Agriculture; Carbon Monoxide; Chronic Disease; Environmental Exposure; Exercise | 1970 |
Public health aspects of air pollution from diesel vehicles.
Topics: Air Pollution; Carbon; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Female; Fuel Oil | 1974 |
Respiratory disturbances in chronic bronchitis.
Topics: Acid-Base Equilibrium; Adult; Age Factors; Blood; Blood Pressure; Blood Volume; Bronchitis; Carbon D | 1974 |
The use of expiratory forced flows for determining response to bronchodilator therapy.
Topics: Airway Resistance; Bronchodilator Agents; Carbon Monoxide; Chronic Disease; Humans; Isoproterenol; L | 1972 |
Oxyhemoglobin affinity in bronchial asthma: chronic stable state, acute, and status asthmaticus.
Topics: Acute Disease; Adult; Asthma; Carbon Dioxide; Carbon Monoxide; Chronic Disease; Erythrocytes; Female | 1972 |
[Patterns of lung function in moderate chronic bronchitis and allergic asthma].
Topics: Adult; Air; Airway Resistance; Asthma; Bronchitis; Carbon Monoxide; Chronic Disease; Humans; Lung; M | 1972 |
[Active-smoking and passive-smoking].
Topics: Adolescent; Adult; Air Pollution; Bronchial Neoplasms; Bronchitis; Carbon Monoxide; Child; Chronic D | 1972 |
Regulation of respiration during oxygen breathing in chronic obstructive lung disease.
Topics: Acidosis; Airway Resistance; Arteries; Bicarbonates; Carbon Dioxide; Carbon Monoxide; Chronic Diseas | 1973 |
Pulmonary function in chronic alcoholism.
Topics: Adult; Alcoholism; Carbon Monoxide; Chronic Disease; Female; Humans; Lung Compliance; Lung Diseases, | 1973 |
[Steady-state CO pulmonary diffusing capacity in chronic pulmonary diseases].
Topics: Adolescent; Adult; Carbon Monoxide; Chronic Disease; Female; Humans; Lung Diseases; Male; Middle Age | 1973 |
[Frequency of chronic bronchitis in different socio-occupational groups. II. Workers of a steel factory (author's transl)].
Topics: Adult; Alloys; Bronchitis; Carbon Monoxide; Chronic Disease; Environmental Exposure; France; Humans; | 1974 |
Membrane diffusing capacity and pulmonary capillary blood volume in chronic obstructive lung disease.
Topics: Blood Volume; Bronchitis; Capillaries; Carbon Monoxide; Chronic Disease; Female; Hemoglobins; Humans | 1972 |
Lung function studies in asbestos workers.
Topics: Adult; Aged; Airway Obstruction; Asbestosis; Bronchitis; Carbon Monoxide; Chronic Disease; Female; H | 1972 |
[Chronic carbon monoxide poisoning].
Topics: Air Pollution; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Humans; Occupational Dis | 1972 |
[Pulmonary diffusing capacity and regional pulmonary function].
Topics: Adolescent; Adult; Aged; Asthma; Carbon Monoxide; Chronic Disease; Female; Heart Septal Defects, Atr | 1971 |
[Functional respiratory investigations. Ductance of CO (carbon monoxide): global estimation of pulmonary exchanger, omitting blood tests].
Topics: Adult; Blood Gas Analysis; Bronchitis; Carbon Monoxide; Chronic Disease; Humans; Infant, Newborn; Lu | 1971 |
The relative importance of clinical, radiological and pulmonary function variables in evaluating asbestosis and chronic obstructive airway disease in asbestos workers.
Topics: Adult; Asbestosis; Carbon Monoxide; Chronic Disease; Cough; Diagnosis, Differential; Humans; Lung Di | 1971 |
Pulmonary gas transport characterization by a dynamic model.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Humans; Lung Diseases, Obstructive; Middle Aged; Mode | 1971 |
Relation between single-breath diffusing capacity and arterial blood gases in chronic obstructive lung disease.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Diffusion; Female; Granuloma; Humans; Hypoxia; Lung D | 1968 |
On the prediction of pulmonary diffusing capacity with a steady state carbon monoxide method in chronic lung diseases.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Diffusion; Female; Heart Rate; Humans; Lung Diseases; | 1969 |
A comparison of pulmonary function in bronchial asthma and chronic obstructive bronchitis.
Topics: Adolescent; Adult; Aged; Asthma; Bronchitis; Carbon Dioxide; Carbon Monoxide; Child; Chronic Disease | 1970 |
Relation between rebreathing CO-diffusing capacity of the lung and unequal ventilation.
Topics: Adult; Aged; Carbon Dioxide; Carbon Monoxide; Chronic Disease; Diffusion; Female; Helium; Humans; Lu | 1970 |
Ischemic retinopathy due to carbon monoxide poisoning.
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Child; Chronic Disease; Environmental Exposure; Eye Dise | 1971 |
Application of the single-breath method of total lung capacity measurement to the calculation of the carbon monoxide diffusing capacity.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Helium; Humans; Lung; Lung Diseases; Male; Methods; M | 1968 |
Carbon monoxide and coronary heart disease.
Topics: Adult; Arteriosclerosis; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Coronary Disea | 1969 |
[Demonstration of carbon monoxide in the diagnosis of CO poisoning].
Topics: Air; Biological Transport; Carbon Dioxide; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disea | 1969 |
[Indirect determination of carbon monoxide in blood].
Topics: Asthenia; Carbon Monoxide; Carbon Monoxide Poisoning; Chronic Disease; Headache; Hemoglobins; Humans | 1966 |